American Vietnamese Biotech, Inc. (AMV) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

American Vietnamese Biotech, Inc.

Why is American Vietnamese Biotech, Inc. ?

With a fall in PBT of -293.91%, the company declared Very Negative results in Mar 26

The company has declared negative results for the last 2 consecutive quarters
NET PROFIT(HY) At VND -11,491.45 MM has Grown at -117.96%
ROCE(HY) Lowest at -3.88%
RAW MATERIAL COST(Y) Grown by 390.43% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -35.00%, its profits have fallen by -3375%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -35.00% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is American Vietnamese Biotech, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

American Vietnamese Biotech, Inc.

-35.0%

-1.12

59.49%

Vietnam VN Ho Chi Minh Index

16.45%

0.77

21.41%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.30%

EBIT Growth (5y)

-212.98%

EBIT to Interest (avg)

1.40

Debt to EBITDA (avg)

6.03

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.14

Tax Ratio

0.52%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.88%

ROE (avg)

4.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

1.42

EV to EBITDA

15.67

EV to Capital Employed

-0.04

EV to Sales

-0.53

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-3.89%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -3.39 %

NET PROFIT(Q)

At VND -7,950.11 MM has Grown at 43.88%

-26What is not working for the Company

NET PROFIT(HY)

At VND -11,491.45 MM has Grown at -117.96%

ROCE(HY)

Lowest at -3.88%

RAW MATERIAL COST(Y)

Grown by 390.43% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.29 times

NET SALES(Q)

Lowest at VND 7,233.94 MM

Here's what is working for American Vietnamese Biotech, Inc.

Net Profit

At VND -7,950.11 MM has Grown at 43.88%

over average net sales of the previous four periods of VND -14,167.19 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (VND MM)

Debt-Equity Ratio

Lowest at -3.39 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation

At VND 8,227.87 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (VND MM)

Here's what is not working for American Vietnamese Biotech, Inc.

Net Sales

At VND 7,233.94 MM has Fallen at -81.22%

over average net sales of the previous four periods of VND 38,516.64 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (VND MM)

Net Sales

Lowest at VND 7,233.94 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (VND MM)

Debtors Turnover Ratio

Lowest at 0.29 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 390.43% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales